Second-line antiretroviral therapy: long-term outcomes in South Africa

BACKGROUND: Currently boosted protease inhibitor-containing regimens are the only option after first-line regimen failure available for patients in most resource-limited settings yet little is known about long-term adherence and outcomes. METHODS: We enrolled patients with virologic failure (VF) who...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Murphy, Richard A., Sunpath, Henry, Castilla, Carmen, Ebrahim, Shameez, Court, Richard, Nguyen, Hoang, Kuritzkes, Daniel, Marconi, Vincent C., Nachega, Jean B.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3767995/
https://ncbi.nlm.nih.gov/pubmed/22692090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182615ad1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares